临时关节疾病的前疗法:一个更新的综合性审查
Yesel Kim1, Min-Joong Kim2, Pil-Young Yun3,4
1Electronic Claims Review Division, Claims Review Standards Department, Health Insurance Review and Assessment Service, Wonju, Korea.
Journal of the Korean Association of Oral and Maxillofacial Surgeons
|December 30, 2025
概括
普罗洛疗法为关节疾病 (TMD) 提供了再生治疗,有效减少疼痛并改善部运动. 这种方法显示了作为一种保守的治疗方法,具有最小的副作用的承诺.
科学领域:
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
- 牙科 牙科是指牙科的专业.
- 疼痛管理 疼痛管理
背景情况:
- 关节疾病 (TMD) 是一种复杂的疾病,其特点是疼痛,关节声音和有限的部运动.
- 耐火性TMD通常需要创新的治疗策略超越传统方法.
- 使用再生剂的prolotherapy正在成为TMD的潜在治疗方法.
研究的目的:
- 审查当前的证据和治疗关节 (TMJ) 疾病的prolotherapy的生物机制.
- 评估诸如乳糖和多氧核酸 (PDRN) 等prolotherapy药物的疗效和安全性,用于治疗TMD.
主要方法:
- 系统的文献搜索临床和实验研究的TMJ疾病的前列腺疗法.
- 分析治疗方案,疗效,安全性和prolotherapy药物的生物效应.
- 对患者结果的审查,包括减少疼痛和改善运动范围.
主要成果:
- 普罗洛疗法刺激纤维细胞活动,原蛋白生产和带修复,促进组织再生.
- 超性乳糖是一种经过良好的验证的增殖剂;聚二氧化核酸 (PDRN) 显示出类似的疗效,改善了患者的舒适度.
- 临床研究报告说,慢性和退行性关节疾病患者的疼痛显著减少,口腔的最大开口增加.
- 预先的成像表明,在进行prolotherapy后,子冠状腺骨的骨重塑.
- 与prolotherapy相关的不良事件通常是轻微的和暂时的.
结论:
- 普罗洛疗法代表了一种有前途的再生和保守治疗模式,用于关节疾病.
- 它有效地缓解疼痛并改善TMD患者下功能.
- 需要进一步的严格,受控的研究来证实长期的临床益处和结构变化.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Centrally Acting Muscle Relaxants: Therapeutic Uses
1.2K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.2K


